#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypoparathyroidism Osteomyelitis Thalassaemia Renal cell carcinoma Severe myoclonic epilepsy of infancy Oesophageal squamous cell carcinoma stage II Head and neck cancer Cystic fibrosis lung Idiopathic inflammatory myopathy Leukaemia Spinal cord injury cervical Malignant fibrous histiocytoma Amyotrophic lateral sclerosis Autoimmune demyelinating disease Asthma More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Basic Information Lymphangiosarcoma – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Stevens-Johnson syndrome Prader-Willi syndrome – Treatment Biotinidase deficiency – Treatment Primary biliary cholangitis – Basic Information Richter’s syndrome – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Ehlers-Danlos syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propafenone Hydrochloride Murcidencel Pregabalin Corifollitropin Alfa Oxacillin Epinephrine Bitartrate Anhydrous Cidofovir GSKVX000000048110 Wt1/Il15/Il15Ra Mrna Dc Cefotaxime Dosulepin Hydrochloride Dazodalibep Buparlisib Deflazacort Disitamab Vedotin Amivantamab [18F]-Altanserin Zoledronic Acid Ro7589655 LY3841136 SODIUM More therapies…

    Learn about Your Condition

    Choroidal neovascularisation Renal cell carcinoma stage IV Tuberculosis Oral neoplasm Prostatitis Escherichia coli Vulvovaginal pruritus Advanced systemic mastocytosis B-cell type acute leukaemia Myofascial pain syndrome Endometrial cancer stage IV Agitation Thyroidectomy Erdheim-Chester disease Diabetes insipidus Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Low-Dose Acetylsalicylic Acid in Patients with Bipolar Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    Poland

  • Comparison of Two Vitamin D3 Doses (500,000 IU vs 750,000 IU) in Critically Ill Patients with Vitamin D Deficiency Receiving Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    Poland

  • Study on Venous Thromboembolism Prevention with Enoxaparin Sodium and Drug Combination for Patients Undergoing Total Hip or Knee Replacement

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Andexanet Alfa
    • Dalteparin Sodium
    • Enoxaparin Sodium
    The Netherlands

  • Study of leuprorelin and progestogen treatment in women with adenomyosis undergoing assisted reproductive technology to improve pregnancy outcomes

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin Acetate
    Italy

  • Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Human Neuronal Progenitor/Stem Cells
    • Tacrolimus
    Italy

  • Study on Managing Heart Failure and Kidney Disease in Elderly Patients with High Potassium Risk Using Sodium Zirconium Cyclosilicate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain
Previous Page
1 … 335 336 337 338 339 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!